Cite
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
MLA
van Heeswijk, R. P., et al. “Once-Daily Dosing of Saquinavir and Low-Dose Ritonavir in HIV-1-Infected Individuals: A Pharmacokinetic Pilot Study.” AIDS (London, England), vol. 14, no. 9, June 2000, pp. F103–10. EBSCOhost, https://doi.org/10.1097/00002030-200006160-00003.
APA
van Heeswijk, R. P., Veldkamp, A. I., Mulder, J. W., Meenhorst, P. L., Lange, J. M., Beijnen, J. H., & Hoetelmans, R. M. (2000). Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study. AIDS (London, England), 14(9), F103–F110. https://doi.org/10.1097/00002030-200006160-00003
Chicago
van Heeswijk, R P, A I Veldkamp, J W Mulder, P L Meenhorst, J M Lange, J H Beijnen, and R M Hoetelmans. 2000. “Once-Daily Dosing of Saquinavir and Low-Dose Ritonavir in HIV-1-Infected Individuals: A Pharmacokinetic Pilot Study.” AIDS (London, England) 14 (9): F103–10. doi:10.1097/00002030-200006160-00003.